|Articles|August 1, 2014
- BioPharm International-08-01-2014
- Volume 27
- Issue 8
BioPharm International, August 2014 Issue (PDF)
Click the title above to open the BioPharm International August 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Single-Domain Antibodies for Brain Targetingover 11 years ago
Marrying Big Data with Personalized Medicineover 11 years ago
Applying GMPs to the BioPharma Supply Chainover 11 years ago
Changes and Challenges for Generic Drugsover 11 years ago
Optimizing Human Performance, Part II: A Road Worth TravelingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
